TH
Taqtik Health Inc
Verified
San Francisco, United States · B2B SaaS
B2B SaaS Seed Founded 2024
software dashboard screens

Overview

Taqtik Health Inc is a B2B SaaS company that provides an AI-driven remote patient monitoring platform. The platform is designed to support patients following bariatric surgery and during weight loss therapies through continuous digital monitoring and engagement.

The company addresses a documented clinical challenge in post-operative care. Research indicates that up to 30 per cent of patients may experience weight regain following bariatric surgery, partly due to limited follow-up care and insufficient daily structure during the recovery period. Taqtik Health's platform aims to bridge this gap by providing ongoing support to patients after their procedures.

Activities and products

Taqtik Health's primary offering is a remote patient monitoring platform that uses artificial intelligence to track and support patients in the post-bariatric and weight loss care space. The platform enables continuous monitoring of patients outside traditional clinical settings, allowing healthcare providers to maintain engagement with patients during their recovery and weight management journey. The specific clinical features and technical specifications of the platform are not detailed in available information.

Stage and funding

Taqtik Health was founded in 2024 and is currently at seed stage. The company raised $6 million in seed funding during 2024. The company is headquartered in San Francisco, United States, and was founded by Yasuhiro and Rachel. Further details regarding investors or subsequent funding rounds are not available.

Photograph: Advantage Video Productions / Unsplash

Company details

Legal name
Taqtik Health Inc
Website
taqtikhealth.com
Headquarters
San Francisco, United States
Founded
2024
Sector
B2B SaaS
Funding stage
Seed

Verification

Verified profile
Reviewed by Ana Pereira on 31 May 2026. Primary source: taqtikhealth.com. For corrections or removal, contact [email protected].